Quantcast

Latest Diabetes mellitus type 1 Stories

2014-07-08 23:12:38

Fit4D’s Pathways optimizes the mix between intelligent technology and human touch points to personalize the experience for patients while using claim and pharmacy data to measure health improvements. New York, New York (PRWEB) July 08, 2014 Fit4D© (http://www.fit4d.com) announced today that it is partnering with Healthfirst to deliver an evidence-based diabetes program to Healthfirst’s Spanish speaking members with poorly managed diabetes in New York City. This program will...

2014-07-08 23:09:30

Market Size - $1,136.2 million in 2013, Market Growth - CAGR of 15.0%, Market Trends– Introduction of ultra-long and ultra-fast acting insulin such as Tresiba new report by Grand View Research. View full report with TOC - http://www.grandviewresearch.com/industry-analysis/cis-insulin-market. San Francisco, California (PRWEB) July 08, 2014 The CIS market for insulin and insulin products is expected to reach USD 3,008.5 million by 2020 growing at a CAGR of 15.0%, according to a new study...

2014-07-08 16:20:35

- Carson Magee, an 11-year-old fifth grader from Coeur d'Alene, Idaho who was diagnosed with type 1 diabetes (T1D) four years ago at age 7, has won the "Our Everyday Heroes" Race Car Design Contest for JDRF, hosted by Ford Customer Service Division (FCSD) and its brands, Motorcraft and Quick Lane Tire and Auto Centers. DEARBORN, Mich., July 8, 2014 /PRNewswire/ -- Carson Magee, an 11-year-old fifth grader from Coeur d'Alene, Idaho who was diagnosed with type 1 diabetes (T1D) four...

2014-07-07 16:23:07

On and off the track, Reed shows that diabetes doesn't slow him down INDIANAPOLIS and ALEXANDRIA, Va., July 7, 2014 /PRNewswire/ -- News Highlights: -- #DiabetesChamp & Lilly #Diabetes ambassador @driverRyanReed finishes 4th at the Subway Firecracker 250 -- Lilly #Diabetes ambassador & @NASCAR driver @driverRyanReed takes 4th place at Subway Firecracker 250. Great job! #D2SD -- Lilly #Diabetes & @AmDiabetesAssn congratulate NASCAR driver...

2014-07-07 12:24:22

LONDON, July 7, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: MarketVIEW: diabetes vaccineshttp://www.reportbuyer.com/pharma_healthcare/therapeutic/marketview_diabetes_vaccines.html Diabetes is a metabolic disorder where the pancreas produces little or no insulin (Type I) OR cells do not respond appropriately to insulin that is produced (Type II). It is estimated that the global prevalence of diabetes is estimated at over 371 million people, a number...

early celiac sign
2014-07-04 03:30:55

NIH/National Institute of Diabetes and Digestive and Kidney Diseases NIH-funded study finds higher celiac risk in Sweden than US, elsewhere More than one quarter of children with two copies of a high-risk variant in a specific group of genes develop an early sign of celiac disease called celiac disease autoimmunity (CDA) by age 5. The findings are from The Environmental Determinants of Diabetes in Youth consortium, or TEDDY. The National Institutes of Health-funded study, published July...

Human gastrointestinal cells
2014-06-30 09:12:35

Brett Smith for redOrbit.com - Your Universe Online Type 1 diabetes is caused by the body's immune system attacking its own natural insulin-producing cells to the point where the body cannot properly regulate blood sugar levels. Researchers have been pursuing therapies that could “re-train” the body’s other cells to produce the proper amount of insulin necessary. Now, researchers from Columbia University Medical Center have announced the ability to convert cells in the human...

Afrezza Inhalation Powder
2014-06-29 04:56:44

April Flowers for redOrbit.com - Your Universe Online Treatment options for diabetes come in a wide variety, ranging from oral medications to insulin pumps. USA Today reports that a new treatment option has been added to the arsenal, Afrezza Inhalation Powder. This week, the US Food and Drug Administration (FDA) approved the rapid-acting inhaled insulin to improve glycemic control in adults with diabetes mellitus, or Type I diabetes. The FDA estimates that 25.8 million people in...

2014-06-27 12:26:23

TORONTO, June 27, 2014 /CNW/ - A new partnership between MedicAlert Foundation Canada (MAFCA) and the Canadian Diabetes Association (CDA) means that Canadians living with diabetes will benefit from a special offer on their MedicAlert bracelets. The first to benefit from this partnership are the 1,600 youth attending the CDA's national D-Camps program, launching on June 29. Over the course of the summer, campers who enroll will receive a free $39 Urban Link MedicAlert bracelet...

2014-06-25 08:32:23

Lilly Diabetes grants $200,000 for scholarships ROLLING MEADOWS, Ill. and INDIANAPOLIS, June 25, 2014 /PRNewswire/ -- Managing a chronic disease like type 1 diabetes can be difficult for a person of any age, but can be especially daunting while navigating the halls of high school. The Diabetes Scholars Foundation (Foundation) today announced its 2014 college scholarship recipients--a gifted group of young adults who, in addition to successfully managing their diabetes, have...


Latest Diabetes mellitus type 1 Reference Libraries

Diabetes (journal)
2012-05-12 21:44:48

Diabetes is a peer-reviewed medical journal published since 1952 by the American Diabetes Association. Diabetes is a separate journal from the journal Diabetes Care, which is also published by the ADA. Diabetes covers research about the physiology and pathophysiology of diabetes mellitus, including any aspect of laboratory, animal or human research. Emphasis is on investigative reports focusing on areas such as the pathogenesis of diabetes and its complications, normal and pathologic...

More Articles (1 articles) »
Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related